
TDACU P/E Ratio
P/E Ratio as of Sep 15, 2026: 49.59
Average49.59
Median49.59
Minimum49.59
Maximum49.59
49.59
0.00 (0.00%)past month
The P/E ratio for TDACU is 49.59 as of Sep 15, 2026. This represents a increase of 1.39% compared to its 12-month average P/E ratio of 48.91. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Translational Development Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Translational Development Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Translational Development Acquisition Corp to industry peers.
Translational Development Acquisition Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Translational Development Acquisition Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Translational Development Acquisition Corp to industry peers.
TDACU P/E Ratio Insights
See Translational Development Acquisition Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TDACU
Order type
Buy in
Order amount
Est. shares
0 shares
TDACU P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Sep 1, 2026 | — | 49.59 |
| Aug 3, 2026 | — | 44.32 |
| Jul 1, 2026 | — | 39.88 |
| Jun 1, 2026 | $10.71 | 37.76 |
| May 1, 2026 | $10.44 | 35.95 |
| Apr 1, 2026 | — | 35.95 |
| Mar 2, 2026 | — | 48.07 |
| Feb 2, 2026 | — | 48.07 |
| Jan 2, 2026 | — | 48.07 |
TDACU End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 49.59 | +3.16% |
| 2025 | 48.07 | — |
FAQs About Translational Development Acquisition Corp (TDACU) P/E ratio
The latest P/E ratio of TDACU is 49.59, as of Sep 15, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Translational Development Acquisition Corp’s last 12-month average P/E ratio is 48.91, compared to its current P/E ratio of 49.59. This reflects a increase of 1.39%.
Translational Development Acquisition Corp’s current P/E ratio of 49.59 is higher than its last 12-month average P/E of 48.91. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Translational Development Acquisition Corp’s average P/E ratio over the last 3 years is 22.57. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Translational Development Acquisition Corp’s average P/E ratio over the last 5 years is 13.54. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.